SC 13G: Mineralys Therapeutics, Inc.
Ticker: MLYS · Form: SC 13G · Filed: Feb 13, 2024 · CIK: 1933414
Sentiment: neutral
Topics: sc-13g
AI Summary
SC 13G filing by Mineralys Therapeutics, Inc..
Risk Assessment
Risk Level: low
Filing Stats: 1,331 words · 5 min read · ~4 pages · Grade level 11.4 · Accepted 2024-02-13 16:12:05
Key Financial Figures
- $0.0001 — of Securities Common Stock, par value $0.0001 per share ("Common Stock"). (e) CUSIP
Filing Documents
- a2024021313g.htm (SC 13G) — 109KB
- a2024021313gex991.htm (EX-99.1) — 12KB
- 0001628280-24-004464.txt ( ) — 123KB
(a) Name of Issuer
ITEM 1. (a) Name of Issuer Mineralys Therapeutics, Inc. (the "Issuer"). (b) Address of Issuer's Principal Executive Offices 150 N. Radnor Chester Rd, Suite F200, Radnor, PA 19087
(a) Name of Person Filing
ITEM 2. (a) Name of Person Filing Each of the following is hereinafter individually referred to as a "Reporting Person" and collectively as the "Reporting Persons." This statement is filed on behalf of Catalys Pacific Fund, LP Catalys Pacific Fund GP, LP Catalys Pacific, LLC Brian Taylor Slingsby (b) Address or Principal Business Office The principal business address for Catalys Pacific Fund, LP, Catalys Pacific Fund GP, LP and Catalys Pacific, LLC is PO Box 309, Ugland House, Grand Cayman, KY1-1104, Cayman Islands. The principal business address for Brian Taylor Slingsby is 1516 Bigelow Ave N, Seattle, WA 98109. (c) Citizenship of each Reporting Person is Brian Taylor Slingsby is a citizen of the United States. The other Reporting Persons are each entities organized under the laws of the Cayman Islands. (d) Title of Class of Securities Common Stock, par value $0.0001 per share ("Common Stock"). (e) CUSIP Number 603170101 ITEM 3. Not applicable.
Ownership
ITEM 4. Ownership. (a-c) The ownership information presented below represents beneficial ownership of Common Stock of the Issuer as of December 31, 2023, based upon 41,105,118 shares of Common Stock outstanding as of November 1, CUSIP No. 603170101 Schedule 13G Page 6 of 9 2023, as disclosed in the Issuer's Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 7, 2023. Reporting Person Amount beneficially owned Percent of class Sole power to vote or to direct the vote Shared power to vote or to direct the vote Sole power to dispose or to direct the disposition of Shared power to dispose or to direct the disposition of Catalys Pacific Fund, LP 9,209,245 22.4% 0 9,209,245 0 9,209,245 Catalys Pacific Fund GP, LP 9,209,245 22.4% 0 9,209,245 0 9,209,245 Catalys Pacific, LLC 9,209,245 22.4% 0 9,209,245 0 9,209,245 Brian Taylor Slingsby 9,209,245 22.4% 0 9,209,245 0 9,209,245 Catalys Pacific Fund, LP is the beneficial owner of 9,223,912 shares of Common Stock, which includes 9,194,579 shares of Common Stock held of record by Catalys Pacific Fund, LP and 14,666 shares of Common Stock underlying stock options that are exercisable within 60 days of December 31, 2023. Catalys Pacific Fund GP, LP is the general partner of Catalys Pacific Fund, LP. Catalys Pacific, LLC is the general partner of Catalys Pacific Fund GP, LP. Brian Taylor Slingsby is the managing director of Catalys Pacific, LLC. As a result, each of the Reporting Persons may be deemed to share beneficial ownership over the securities reported herein.
Ownership of Five Percent or Less of a Class
ITEM 5. Ownership of Five Percent or Less of a Class. Not applicable.
Ownership of More than Five Percent on Behalf of Another Person
ITEM 6. Ownership of More than Five Percent on Behalf of Another Person. Not applicable. ITEM 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company. Not applicable.
Identification and Classification of Members of the Group
ITEM 8. Identification and Classification of Members of the Group. Not applicable.
Notice of Dissolution of Group
ITEM 9. Notice of Dissolution of Group. Not applicable. CUSIP No. 603170101 Schedule 13G Page 7 of 9
Certification
ITEM 10. Certification. Not applicable. CUSIP No. 603170101 Schedule 13G Page 8 of 9 SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Date February 13, 2024 Catalys Pacific Fund, LP By Catalys Pacific Fund GP, LP, its General Partner By Catalys Pacific, LLC, its General Partner By s Brian Taylor Slingsby Name Brian Taylor Slingsby Title Managing Director Catalys Pacific Fund GP, LP By Catalys Pacific, LLC, its General Partner By s Brian Taylor Slingsby Name Brian Taylor Slingsby Title Managing Director Catalys Pacific, LLC By s Brian Taylor Slingsby Name Brian Taylor Slingsby Title Managing Director s Brian Taylor Slingsby CUSIP No. 603170101 Schedule 13G Page 9 of 9 LIST OF EXHIBITS Exhibit No. Description 99 Joint Filing Agreement.